[1]
Hermawan, G.N. , Laihad, B.J. , Wagey, F.M.M. , Mongan, S.P. and Aprilia, B. 2025. Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis. International Journal of Innovative Research and Scientific Studies. 8, 4 (Jun. 2025), 1223–1232. DOI:https://doi.org/10.53894/ijirss.v8i4.8050.